loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Fidaxomicin

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Fidaxomicin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Actavis` Generic Fidaxomicin Receives Approval in the U.S.
    Actavis` Generic Fidaxomicin Receives Approval in the U.S.

    16 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208443

    FDA
    16 Jan 2024
    Share Share
    Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection
    Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection

    07 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211207005586/en

    BUSINESSWIRE
    07 Dec 2021
    Share Share
    Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results
    Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results

    12 Oct 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201012005201/en

    BUSINESSWIRE
    12 Oct 2020
    Share Share
    Astellas Submits Application for Approval of fidaxomicin Infectious Enteritis
    Astellas Submits Application for Approval of fidaxomicin Infectious Enteritis

    31 Jul 2017

    // ASTELLAS

    https://www.astellas.com/en/corporate/news/detail/astellas-submits-application-f.html

    ASTELLAS
    31 Jul 2017
    Share Share
    After Delay, Merck Gets US Approval for Serious Infection Drug
    After Delay, Merck Gets US Approval for Serious Infection Drug

    25 Oct 2016

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/after_delay,_merck_gets_us_approval_for_serious_infection_drug_1174395

    Phil Taylor PMLIVE
    25 Oct 2016
    Share Share